February 14 - 17, 2018
Manchester Grand Hyatt
San Diego, California
Abstract submission deadline: Monday, November 6
Advance registration deadline: Monday, December 18
Advance Registration Deadline: Monday, Dec. 18, 2017
Program CommitteeCarolyn J. Anderson, University of Pittsburgh School of Medicine, Pittsburgh, PennsylvaniaChristopher H. Contag, Michigan State University, East Lansing, MichiganYibin Kang, Princeton University, Princeton, New JerseyKimberly A. Kelly, University of Virginia, Charlottesville, VirginiaH. Charles Manning, Vanderbilt-Ingram Cancer Center, Nashville, TennesseeMark “Marty” Pagel, The University of Texas MD Anderson Cancer Center, Houston, Texas
The AACR-SNMMI Joint Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy will focus on cutting-edge research in molecular imaging research as applied to cancer biology and therapy.
In a focused, small-meeting setting, this event will bring together imaging scientists with physicians and cancer biologists in basic, translational, and clinical research to discuss, promote, and support the application and use of molecular imaging in cancer biology and therapy.
Together, attendees will explore how new findings in molecular imaging can improve cancer diagnostics, treatment, and patient outcomes. The conference also offers a unique, collaborative structure of didactic lectures, poster presentations, and opportunities for participation from junior scientists, as short talks will be selected from the most highly rated abstracts.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available.
The SNMMI’s Verification of Involvement in Continuing Education (VOICE) credit program is recognized by most licensure states and by the NMTCB and ARRT as Category A and A+ credit.